Search research articles
Contact Us
Filters
Showing results (131-140 of 157) with videos related to
Page
of 16
Sort By:
Current Oncology (Toronto, Ont.)
|
October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network
Giuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2019
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer
Vincenza Conteduca, Elena Castro, Daniel Wetterskog, et al.
The Oncologist
|
July 3, 2026
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study
Giuseppe Neola, Fabiano Flauto, Carmine Caso, et al.
European Urology Oncology
|
June 3, 2025
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience
Giuseppina Bruno, Maria Iole Natalicchio, Marianna Garofoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2021
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis
Jacob E Berchuck, Sylvan C Baca, Heather M McClure, et al.
European Urology Oncology
|
July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Pasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
Oncotarget
|
November 9, 2016
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review
Francesco Jacopo Romano, Sabrina Rossetti, Vincenza Conteduca, et al.
European Urology
|
February 19, 2019
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
Vincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, et al.
JCO Precision Oncology
|
September 14, 2020
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis
Anuradha Jayaram, Anna Wingate, Daniel Wetterskog, et al.
The Oncologist
|
December 2, 2025
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study
Lorena Incorvaia, Mattia Puglisi, Marco Maruzzo, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 157) with videos related to
Sort By:
Page
of 16
Current Oncology (Toronto, Ont.)
|
October 27, 2022
The Geriatric G8 Score Is Associated with Survival Outcomes in Older Patients with Advanced Prostate Cancer in the ADHERE Prospective Study of the Meet-URO Network
Giuseppe Luigi Banna, Umberto Basso, Emilio Francesco Giunta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 15, 2019
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer
Vincenza Conteduca, Elena Castro, Daniel Wetterskog, et al.
The Oncologist
|
July 3, 2026
The Impact of Relative Dose Intensity on pCR in Neoadjuvant Chemotherapy of Muscle-Invasive Urothelial Cancer: a Multicentre Retrospective Study
Giuseppe Neola, Fabiano Flauto, Carmine Caso, et al.
European Urology Oncology
|
June 3, 2025
Real-World Outcomes and Molecular Profiling for Patients with Metastatic Castration-resistant Prostate Cancer with Lung Metastases: A Long-term Multicenter Experience
Giuseppina Bruno, Maria Iole Natalicchio, Marianna Garofoli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 15, 2021
Detecting Neuroendocrine Prostate Cancer Through Tissue-Informed Cell-Free DNA Methylation Analysis
Jacob E Berchuck, Sylvan C Baca, Heather M McClure, et al.
European Urology Oncology
|
July 17, 2019
Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis
Pasquale Rescigno, David Dolling, Vincenza Conteduca, et al.
Oncotarget
|
November 9, 2016
Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review
Francesco Jacopo Romano, Sabrina Rossetti, Vincenza Conteduca, et al.
European Urology
|
February 19, 2019
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
Vincenza Conteduca, Anuradha Jayaram, Nuria Romero-Laorden, et al.
JCO Precision Oncology
|
September 14, 2020
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis
Anuradha Jayaram, Anna Wingate, Daniel Wetterskog, et al.
The Oncologist
|
December 2, 2025
Homologous recombination repair genetic testing variables and diagnostic paths for prostate cancer patients: a multicenter cohort study
Lorena Incorvaia, Mattia Puglisi, Marco Maruzzo, et al.
Page
of 16